longevity Clinical Trials

12 recruitingLast updated: May 11, 2026

There are 12 actively recruiting longevity clinical trials across 8 countries. Studies span Not Applicable, Phase 2, Phase 3. Top locations include New York, New York, United States, Vienna, State of Vienna, Austria, Galveston, Texas, United States. Updated daily from ClinicalTrials.gov.


longevity Trials at a Glance

12 actively recruiting trials for longevity are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in New York, Vienna, and Galveston. Lead sponsors running longevity studies include University of Vienna, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, and Albert Einstein College of Medicine.

Browse longevity trials by phase

Treatments under study

About longevity Clinical Trials

Looking for clinical trials for longevity? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new longevity trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about longevity clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

The Effects of PeptiStrong and Whey on Muscle Function In Older Adults

longevityHealthy AgeingMuscle Function+4 more
Nuritas Ltd80 enrolled1 locationNCT07528469
Recruiting
Not Applicable

Collagen Peptides and Cellular Aging

longevityHealthy AgingBiological Ageing
University of Vienna125 enrolled1 locationNCT07456449
Recruiting
Not Applicable

A Randomized Controlled Trial of a Multi-domain Smartphone Intervention Incorporating Generative AI for Healthy Older Adults

Healthy Longevity
Tatsuhiro Hisatsune300 enrolled1 locationNCT07524478
Recruiting
Phase 2

Tirzepatide to Slow Biological Aging

AgingLONGEVITY 1
The University of Texas Medical Branch, Galveston90 enrolled1 locationNCT07220473
Recruiting
Not Applicable

Kaempferol Absorption and Pharmacokinetics Evaluation

longevityHealthy VolunteersNo Disease+2 more
University of Pittsburgh120 enrolled3 locationsNCT07322406
Recruiting
Not Applicable

L-serine and Strength Training in the Elderly

longevityHealthy AgeingStrength Training Effects+6 more
University of Vienna126 enrolled1 locationNCT07466290
Recruiting

The Longevity Genes in Founder Populations Project

Extreme Longevity
Albert Einstein College of Medicine2,000 enrolled2 locationsNCT00707694
Recruiting
Phase 2Phase 3

Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation

longevityAgingGLP - 1+1 more
AgelessRx150 enrolled1 locationNCT07092618
Recruiting

TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models

Discogenic PainNeuroplasticityNGS+6 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico200 enrolled1 locationNCT06372054
Recruiting

Longevity Families of the Netherlands

longevityAgingExtreme Longevity+1 more
Leiden University Medical Center600 enrolled1 locationNCT06374069
Recruiting

Effect of lactose vs sucrose after exercise on postprandial blood glucose control.

Sedentary behaviour (elevated CVD risk and reduced longevity)
School of Sport, Exercise, and Nutrition, Massey University12 enrolled1 locationACTRN12622000907741
Recruiting

The Healthy Optimal Australian Microbiome (HOAM) Study

longevitycentenarianoptimal health+1 more
University of New South Wales (UNSW) Sydney550 enrolled3 locationsACTRN12620000106932